New online biotechnology course opportunities for Terms 2 and 3
Due to COVID-19, BABS has decided to offer undergraduate students the opportunity to take two fully on-line courses that have been developed for the new UNSW Graduate Certificate in Commercial Biotechnology. The classes are delivered in a flexible asynchronous yet interactive manner, with class and group discussions, and opportunities to discuss course concepts and case study examples with industry experts. Students will be assessed on their ability to prepare professional business analyses and strategic reports, with no final exams. Both courses are open to students with a minimum of 72 UOC of a bioscience based undergraduate degree.
Term 2: BABS7010 Introduction to Biotechnology Commercialisation
(Note: can be substituted for BABS3071 Commercial Biotechnology in the Biotechnology major or program. Cannot be taken by students who have completed or plan to take BABS3071)
During the course, students are introduced to the issues and challenges facing leaders of public and private sector organizations, and communities seeking to achieve shared goals within the global biotechnology industry. The course brings together diverse academic science and business disciplines (science, regulatory affairs, marketing, finance, legal, ethics, communication, and intellectual property management). It explores how these disciplines can be used as powerful tools to create effective leadership, and productive collaborations within the global industry, while improving managerial decision making. The course provides an overview of the global industry, its infrastructure, and the barriers and opportunities with specific attention to the US, European Australasian and Asian markets.
Term 3: BABS7020 Biotechnology Commercialisation Strategy in Australia and Asia
(suitable as a free elective)
Through case studies, this course explores how scientific discovery is developed into intellectual property and how product and service opportunities based on this IP are identified and evaluated for commercial potential. Using real IP for platform technologies, students will identify, define, strategize and prioritise pipelines for commercialisation in the major markets of the US and Europe. The analysis will include a commercialisation strategy address Australasian and Asian markets.